Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices, will provide an update on its business and address its 2023-2025 business growth strategy and financial goals during its 2022 Analyst &
Today, 12:36 AM
U.S.-listed Chinese electric carmaker Nio Inc (NYSE: NIO) on Friday made its debut on the Singapore stock exchange, with shares jumping 20% in early trading, as it laid out plans to open a local research center focused on artificial intelligence and self-driving cars.
Akari Therapeutics Presents Results From The CASCADE And CORONET Studies In COVID-19 At The American Thoracic Society 2022 Annual Meeting
Yesterday, 4:05 PM
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases, presented results from the CASCADE and CORONET studies in
Yesterday, 11:50 AM
VeeCon 2022 kicks off Thursday, May 19 featuring speakers, panels and experiences connecting the non-fungible token community. Here are the details.
Celldex Announces Acceptance Of Abstract For Barzolvolimab Phase 1b Results In Chronic Spontaneous Urticaria For Late-Breaking Presentation At The European Academy Of Allergy And Clinical Immunology (EAACI) Annual Congress 2022
Yesterday, 9:26 AM
Celldex Announces Acceptance of Abstract for Barzolvolimab Phase 1b Results in Chronic Spontaneous Urticaria for Late-Breaking Presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual
VBI Vaccines Presented Health Economics And Outcomes Research For PreHevbrio At The International Society For Pharmacoeconomics And Outcomes Research 2022
Yesterday, 8:06 AM
VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that health economics and outcomes research
Bristol Myers Squibb Data At ASCO And EHA 2022 Highlight Progress In Transforming Treatment For Patients With Cancer And Blood Disorders
Yesterday, 6:59 AM
Long-term data from Opdivo plus Yervoy-based combinations demonstrate durable survival in metastatic non-small cell lung cancer (NSCLC) and metastatic melanoma, including results from landmark five-year analysis of
May 17, 4:36 PM
Meet Ming Zhao, CEO and founder of Atomic Vaults and popularly known as @FabiusMercurius by thousands of retail traders on Twitter. She believes that the industry is systematically biased against retail investors and said she sets out to change the future of options trading by doing something rather monumental.
May 17, 4:33 PM
While investment results in the markets are not guaranteed, there are relatively simple options strategies that can greatly reduce risk and generate far more predictable returns in the long run.